Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMD-1041 in COPD
NCT00883584Phase 2Unknown
- Sponsor
- Institute of Medicinal Molecular Design, Inc.
- Start
- Jul 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of IMD-1041 in chronic obstructive pulmonary disease (COPD), sponsored by Institute of Medicinal Molecular Design, Inc.. Status: unknown.
02
Drugs
IMD-1041
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00883584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883584.